LYTIR

Insider · SEC Form 4 · 10% Owner

Vivo Opportunity, LLC

In the 12 months to Nov 8, 2026, on the open market: bought $42K of INM. Filed a median of 1 business day after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $42K in total; Insider sales: $0 in total.Jun: Insider purchases $924Jul: Insider purchases $41KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $42KInsider sales below: $0
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. INMBought: InMed Pharmaceuticals Inc. Jul 16, 2026 21 shares filed Jul 16, 2026 2 transactions filing $33
  2. INMBought: InMed Pharmaceuticals Inc. Jul 15, 2026 15,150 shares filed Jul 16, 2026 2 transactions filing $23K
  3. INMBought: InMed Pharmaceuticals Inc. Jul 14, 2026 5,375 shares filed Jul 16, 2026 2 transactions filing $8K
  4. INMBought: InMed Pharmaceuticals Inc. Jul 2, 2026 1,607 shares filed Jul 2, 2026 2 transactions filing $2K
  5. INMBought: InMed Pharmaceuticals Inc. Jul 1, 2026 4,344 shares filed Jul 2, 2026 2 transactions filing $7K
  6. INMBought: InMed Pharmaceuticals Inc. Jun 30, 2026 600 shares filed Jul 2, 2026 2 transactions filing $924

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.